News Post List
Cancer Research UK is becoming an 'opt-in' charity - but what exactly does that mean for you and the way we work?
Cancer Research Technology has signed a further deal with Merck to discover new cancer drugs targeting the Hippo pathway.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
News digest – 8 new grand cancer challenges, blood tests, personalising immunotherapy and… ‘go natural’?
8 new Grand Challenges in cancer research launched, blood tests for prostate cancer, making immunotherapy more personal and… ‘go natural’? Here’s our weekly news digest....
The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found.
An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today.
Cancer Research UK is pleased to announce the appointment of Professor Charles Swanton as its new chief clinician.
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.